Introduction to engineering the biosynthesis of fungal natural products

Research output: Contribution to journalEditorial in journalResearchpeer review

Authors

Research Organisations

External Research Organisations

  • Technische Universität Dresden
View graph of relations

Details

Original languageEnglish
Pages (from-to)7-8
Number of pages2
JournalNatural product reports
Volume40
Issue number1
Publication statusPublished - 9 Jan 2023

Abstract

Filamentous fungi are highly diverse eukaryotes that inhabit all known ecosystems on earth. Estimates suggest that more than 2 × 106 species are likely to exist, and analyses of typical fungal genomes suggest they harbour around 50 biosynthetic gene clusters on average. The biosynthetic potential of these organisms is thus vast. Fungi produce all the main classes of secondary metabolites, and numerous hybrid compounds. Many are highly useful in medicine such as the ‘classic’ special metabolites penicillins, cephalosporins, statins and mycophenolic acid, and new antimicrobial agents such as the pleuromutilins and enfumafungins that overcome specific patterns of resistance. Fungi differentiated from bacteria more than a billion years ago, so there has been plenty of time for uniquely fungal biosynthetic systems to evolve.

ASJC Scopus subject areas

Cite this

Introduction to engineering the biosynthesis of fungal natural products. / Cox, Russell J.; Gulder, Tobias A.M.
In: Natural product reports, Vol. 40, No. 1, 09.01.2023, p. 7-8.

Research output: Contribution to journalEditorial in journalResearchpeer review

Download
@article{821a89b1fabd4d4ea1b55f908e00ef68,
title = "Introduction to engineering the biosynthesis of fungal natural products",
abstract = "Filamentous fungi are highly diverse eukaryotes that inhabit all known ecosystems on earth. Estimates suggest that more than 2 × 106 species are likely to exist, and analyses of typical fungal genomes suggest they harbour around 50 biosynthetic gene clusters on average. The biosynthetic potential of these organisms is thus vast. Fungi produce all the main classes of secondary metabolites, and numerous hybrid compounds. Many are highly useful in medicine such as the {\textquoteleft}classic{\textquoteright} special metabolites penicillins, cephalosporins, statins and mycophenolic acid, and new antimicrobial agents such as the pleuromutilins and enfumafungins that overcome specific patterns of resistance. Fungi differentiated from bacteria more than a billion years ago, so there has been plenty of time for uniquely fungal biosynthetic systems to evolve.",
author = "Cox, {Russell J.} and Gulder, {Tobias A.M.}",
year = "2023",
month = jan,
day = "9",
doi = "10.1039/d2np90047e",
language = "English",
volume = "40",
pages = "7--8",
journal = "Natural product reports",
issn = "0265-0568",
publisher = "Royal Society of Chemistry",
number = "1",

}

Download

TY - JOUR

T1 - Introduction to engineering the biosynthesis of fungal natural products

AU - Cox, Russell J.

AU - Gulder, Tobias A.M.

PY - 2023/1/9

Y1 - 2023/1/9

N2 - Filamentous fungi are highly diverse eukaryotes that inhabit all known ecosystems on earth. Estimates suggest that more than 2 × 106 species are likely to exist, and analyses of typical fungal genomes suggest they harbour around 50 biosynthetic gene clusters on average. The biosynthetic potential of these organisms is thus vast. Fungi produce all the main classes of secondary metabolites, and numerous hybrid compounds. Many are highly useful in medicine such as the ‘classic’ special metabolites penicillins, cephalosporins, statins and mycophenolic acid, and new antimicrobial agents such as the pleuromutilins and enfumafungins that overcome specific patterns of resistance. Fungi differentiated from bacteria more than a billion years ago, so there has been plenty of time for uniquely fungal biosynthetic systems to evolve.

AB - Filamentous fungi are highly diverse eukaryotes that inhabit all known ecosystems on earth. Estimates suggest that more than 2 × 106 species are likely to exist, and analyses of typical fungal genomes suggest they harbour around 50 biosynthetic gene clusters on average. The biosynthetic potential of these organisms is thus vast. Fungi produce all the main classes of secondary metabolites, and numerous hybrid compounds. Many are highly useful in medicine such as the ‘classic’ special metabolites penicillins, cephalosporins, statins and mycophenolic acid, and new antimicrobial agents such as the pleuromutilins and enfumafungins that overcome specific patterns of resistance. Fungi differentiated from bacteria more than a billion years ago, so there has been plenty of time for uniquely fungal biosynthetic systems to evolve.

UR - http://www.scopus.com/inward/record.url?scp=85146176997&partnerID=8YFLogxK

U2 - 10.1039/d2np90047e

DO - 10.1039/d2np90047e

M3 - Editorial in journal

AN - SCOPUS:85146176997

VL - 40

SP - 7

EP - 8

JO - Natural product reports

JF - Natural product reports

SN - 0265-0568

IS - 1

ER -

By the same author(s)